Literature DB >> 11546779

Stimulation of the in vivo production of very low density lipoproteins by apolipoprotein E is independent of the presence of the low density lipoprotein receptor.

B Teusink1, A R Mensenkamp, H van der Boom, F Kuipers, K W van Dijk, L M Havekes.   

Abstract

Apolipoprotein (apo) E stimulates the secretion of very low density lipoproteins (VLDLs) by an as yet unknown mechanism. Recently, a working mechanism for apoE was proposed (Twisk, J., Gillian-Daniel, D. L., Tebon, A., Wang, L., Barrett, P. H., and Attie, A. D. (2000) J. Clin. Invest. 105, 521-532) in which apoE prevents the inhibitory action of the low density lipoprotein receptor (LDLr) by binding to it. We have first tested whether this newly described effect of the LDLr on VLDL secretion, obtained in vitro, is also observed in vivo. In LDLr knockout mice (LDLr-/-), the production of VLDL triglycerides and apoB was 30% higher than that in controls. Also the ratio of apoB100:apoB48 secretion was increased in the LDLr-/- mice. The composition of nascent VLDL was similar in both strains. To test whether the action of apoE depends on the presence of the LDLr, VLDL production was measured in LDLr-/- and apoE-/- LDLr-/- mice. Deletion of apoE on a LDLr-/- background still caused a 50% decrease of VLDL triglycerides and apoB production. The composition of nascent VLDL was again similar for both strains. We conclude that the effect of apoE on hepatic VLDL production is independent of the presence of the LDLr.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11546779     DOI: 10.1074/jbc.M106396200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  6 in total

1.  Recent progress in understanding protein and lipid factors affecting hepatic VLDL assembly and secretion.

Authors:  Meenakshi Sundaram; Zemin Yao
Journal:  Nutr Metab (Lond)       Date:  2010-04-27       Impact factor: 4.169

2.  Regulation of ApoB secretion by the low density lipoprotein receptor requires exit from the endoplasmic reticulum and interaction with ApoE or ApoB.

Authors:  Daniel A Blasiole; Angie T Oler; Alan D Attie
Journal:  J Biol Chem       Date:  2008-02-13       Impact factor: 5.157

3.  Oxidative stress regulates adipocyte apolipoprotein e and suppresses its expression in obesity.

Authors:  Doris Joy Espiritu; Theodore Mazzone
Journal:  Diabetes       Date:  2008-08-04       Impact factor: 9.461

4.  Development of vaccine for dyslipidemia targeted to a proprotein convertase subtilisin/kexin type 9 (PCSK9) epitope in mice.

Authors:  Ryo Kawakami; Yoichi Nozato; Hironori Nakagami; Yuka Ikeda; Munehisa Shimamura; Shota Yoshida; Jiao Sun; Tomohiro Kawano; Yoichi Takami; Takahisa Noma; Hiromi Rakugi; Tetsuo Minamino; Ryuichi Morishita
Journal:  PLoS One       Date:  2018-02-13       Impact factor: 3.240

5.  Low-density lipoprotein receptor is required for cholesteryl ester transfer protein to regulate triglyceride metabolism in both male and female mice.

Authors:  Brian T Palmisano; Sophia Yu; Joshua C Neuman; Lin Zhu; Thao Luu; John M Stafford
Journal:  Physiol Rep       Date:  2021-02

6.  Association between proprotein convertase subtilisin/kexin type 9 and late saphenous vein graft disease after coronary artery bypass grafting: a cross-sectional study.

Authors:  Jing Gao; Hai-Bo Wang; Jian-Yong Xiao; Min Ren; Kathleen Heather Reilly; Yu-Ming Li; Yin Liu
Journal:  BMJ Open       Date:  2018-07-10       Impact factor: 2.692

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.